Metabolic syndrome damages your liver

• May 2, 2024

Liver disease due to fatty deposits is currently considered as the hepatic manifestation of the metabolic syndrome, which, associated with other factors such as obesity and diabetes ("diabesity"), can lead to a chronic liver damage , according to the doctor Francisco Bosques Padilla, professor of the Faculty of Medicine of the Autonomous University of Nuevo Leon (UANL) .

The metabolic syndrome is becoming a common cause of cirrhosis both in the United States and in Latin America, either as a single cause or in combination with alcohol, with the hepatitis C or with both. Many people with cirrhosis have more than one cause of liver damage.

The disease of fatty liver can progress towards cirrhosis and hepatocarcinoma , in addition to that increasingly common is associated with obesity, diabetes, protein malnutrition, coronary artery disease and corticosteroid medications.

Also, the cirrhosis It causes resistance to insulin, a hormone produced by the pancreas that allows the body to use glucose as energy. With insulin resistance, the muscles and fats of the body as well as the cells of the liver They do not use insulin properly.

The pancreas tries to satisfy the demand for insulin by producing more, but excess glucose accumulates in the bloodstream and causes type 2 diabetes, in addition to other manifestations and complications, such as gastropathy, edema, cystis (fluid accumulated in the abdomen), gastropathy and esophageal varices.

To prevent the disease fatty liver , according to the also former president of the Mexican Association of Hepatology and member of Mexican Council of Gastroenterology , it is vital that the metabolic syndrome be avoided through healthy eating habits, adequate weight control and control of sugar and sodium levels in the body.

It is also important to have proper controls for an early detection of hepatitis C virus , avoid high-risk sexual behaviors and have vaccines against Hepatitis A and B .

Video Medicine: The REAL Cause of Non Alcoholic Fatty Liver Disease (NAFLD) (May 2024).